Search results
Eli Lilly inks another radiopharma deal, gaining option to buy startup
BioPharma Dive· 6 days agoDive Brief: Eli Lilly is expanding further into radiopharmaceuticals, inking a deal with Radionetics...
US Regulator Approves Eli Lilly Drug For Early Alzheimer Treatment - News18
News18· 4 days agoThe US Food and Drug Administration (FDA) approved a drug made by Eli Lilly on Tuesday that is...
India panel urges drug regulator to approve Lilly's obesity drug Mounjaro
CNBC Awaaz· 6 days agoAn Indian government-approved expert panel has advised the country's drug regulator to approve the...
India Approves The Weight Loss & Diabetes Drugs: Everything You Need To Know
NDTV· 4 days agoEli Lilly and Co., the pharmaceutical company, has secured the first approvals for the import and...
Govt panel urges drug regulator to approve Lilly's obesity drug Mounjaro
Business Standard India· 6 days agoAn Indian government-approved expert panel has advised the country's drug regulator to approve the...
Meet the new member of Lilly Singh’s family
The Telegraph· 3 days agoIn a recent Instagram post, the Canadian YouTuber introduced her little fur baby, Soca
Eli Lilly’s donanemab wins FDA approval for Alzheimer’s disease
Pharmaceutical Technology· 4 days agoEisai and Biogen must now brace for competition as the US Food and Drug Administration (FDA) has...
FDA approves another Alzheimer's drug that can slow disease in its early stages
Hindustan Times· 5 days agoThe Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday for mild or early cases of dementia caused by Alzheimer’s. It’s only the second drug that’s been convincingly ...
India panel urges drug regulator to approve Lilly's obesity drug Mounjaro - ET HealthWorld | Pharma
The Economic Times· 6 days agoHyderabad: An Indian government-approved expert panel has advised the country's drug regulator to...
Atossa Therapeutics updates protocol for breast cancer treatment trial
Clinical Trials Arena· 6 days agoAtossa Therapeutics has announced a protocol amendment in its ongoing clinical trial of...